Related Experiment Video
Updated: Jul 25, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy
Maurits A Sikking1, Sophie L V M Stroeks1, Michiel T H M Henkens2,3
1Department of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM), 6229 HX Maastricht, The Netherlands.
Insights
Cardiac inflammation in genetic dilated cardiomyopathy (DCM) is linked to earlier disease onset. This suggests inflammation may trigger symptoms in genetically susceptible individuals or represent an early disease phase.
Area of Science:
- Cardiology
- Genetics
- Immunology
Background:
- Genetic factors contribute to up to 40% of dilated cardiomyopathy (DCM) cases.
- Disease presentation and penetrance vary due to genetic and external factors.
- Cardiac inflammation can be triggered externally, revealing underlying genetic predispositions.
Purpose of the Study:
- To investigate cardiac inflammation in patients with genetic DCM.
- To determine if cardiac inflammation correlates with earlier disease onset.
Main Methods:
- Analysis of 113 patients with genetic DCM.
- Endomyocardial biopsy to diagnose cardiac inflammation in 17 patients.
- Comparison of disease onset age between inflamed and non-inflamed groups.
Main Results:
- Patients with cardiac inflammation showed increased white blood, cytotoxic T, and T-helper cell infiltration (p < 0.05).
- Cardiac inflammation was associated with a significantly younger disease onset (50 vs. 53 years, p = 0.015).
- No association found between cardiac inflammation and mortality, heart failure hospitalization, or arrhythmias (HR 0.85, p = 0.74).
Conclusions:
- Cardiac inflammation is linked to earlier disease onset in genetic DCM.
- This may indicate myocarditis as a trigger in genetically susceptible individuals.
- Alternatively, inflammation could represent an early, 'hot-phase' of the disease.
Abstract:
Dilated cardiomyopathy (DCM) has a genetic cause in up to 40% of cases, with differences in disease penetrance and clinical presentation, due to different exogeneous triggers and implicated genes. Cardiac inflammation can be the consequence of an exogeneous trigger, subsequently unveiling a phenotype. The study aimed to determine cardiac inflammation in a cohort of genetic DCM patients and investigate whether it associated with a younger disease onset. The study included 113 DCM patients with a genetic etiology, of which 17 had cardiac inflammation as diagnosed in an endomyocardial biopsy. They had a significant increased cardiac infiltration of white blood, cytotoxic T, and T-helper cells (p < 0.05). Disease expression was at a younger age in those patients with cardiac inflammation, compared to those without inflammation (p = 0.015; 50 years (interquartile range (IQR) 42-53) versus 53 years (IQR 46-61). However, cardiac inflammation was not associated with a higher incidence of all-cause mortality, heart failure hospitalization, or life-threatening arrhythmias (hazard ratio 0.85 [0.35-2.07], p = 0.74). Cardiac inflammation is associated with an earlier disease onset in patients with genetic DCM. This might indicate that myocarditis is an exogeneous trigger unveiling a phenotype at a younger age in patients with a genetic susceptibility, or that cardiac inflammation resembles a 'hot-phase' of early-onset disease.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

